$VRTX VERTEX PHARMACEUTICALS INC / MA Insider Trading Week 44/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA in week 44/2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 155.57 | 1,223 | 190,262 | 11,006 | |
Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 155.57 | 1,223 | 190,262 | 11,006 | |
Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 197.90 | 210 | 41,559 | 31,553 | 31.8 K to 31.6 K (-0.66 %) |
Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 197.90 | 210 | 41,559 | 31,553 | 31.8 K to 31.6 K (-0.66 %) |
Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 197.38 | 770 | 151,983 | 31,763 | 32.5 K to 31.8 K (-2.37 %) |
Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 197.38 | 770 | 151,983 | 31,763 | 32.5 K to 31.8 K (-2.37 %) |
Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 196.08 | 243 | 47,647 | 32,533 | 32.8 K to 32.5 K (-0.74 %) |
Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 196.08 | 243 | 47,647 | 32,533 | 32.8 K to 32.5 K (-0.74 %) |
Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 155.57 | 1,223 | 190,262 | 32,776 | 31.6 K to 32.8 K (+3.88 %) |
Nov 07 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 155.57 | 1,223 | 190,262 | 32,776 | 31.6 K to 32.8 K (+3.88 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,942 | 168,022 | 9,708 | |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 91.05 | 2,155 | 196,213 | 2,156 | |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 201.10 | 1,100 | 221,210 | 33,416 | 34.5 K to 33.4 K (-3.19 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 200.12 | 2,497 | 499,700 | 34,516 | 37 K to 34.5 K (-6.75 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 199.77 | 500 | 99,885 | 37,013 | 37.5 K to 37 K (-1.33 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,942 | 168,022 | 37,513 | 35.6 K to 37.5 K (+5.46 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 91.05 | 2,155 | 196,213 | 35,571 | 33.4 K to 35.6 K (+6.45 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 86.52 | 2,330 | 201,592 | 11,650 | |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 201.37 | 600 | 120,822 | 35,003 | 35.6 K to 35 K (-1.69 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 200.20 | 1,730 | 346,346 | 35,603 | 37.3 K to 35.6 K (-4.63 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 86.52 | 2,330 | 201,592 | 37,333 | 35 K to 37.3 K (+6.66 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 86.52 | 1,553 | 134,366 | 7,767 | |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 91.05 | 2,155 | 196,213 | 2,156 | |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 201.62 | 1,553 | 313,116 | 33,240 | 34.8 K to 33.2 K (-4.46 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 86.52 | 1,553 | 134,366 | 34,793 | 33.2 K to 34.8 K (+4.67 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 201.62 | 2,155 | 434,491 | 33,240 | 35.4 K to 33.2 K (-6.09 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 91.05 | 2,155 | 196,213 | 35,395 | 33.2 K to 35.4 K (+6.48 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 86.52 | 2,330 | 201,592 | 11,650 | |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 91.05 | 1,796 | 163,526 | 1,796 | |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 201.23 | 800 | 160,984 | 31,553 | 32.4 K to 31.6 K (-2.47 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 200.26 | 3,326 | 666,065 | 32,353 | 35.7 K to 32.4 K (-9.32 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 86.52 | 2,330 | 201,592 | 35,679 | 33.3 K to 35.7 K (+6.99 %) |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 91.05 | 1,796 | 163,526 | 33,349 | 31.6 K to 33.3 K (+5.69 %) |
Nov 04 2019 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Option Exercise | M | 152.74 | 1,291 | 197,187 | 1,938 | |
Nov 04 2019 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Sell | S | 200.00 | 1,291 | 258,200 | 5,249 | 6.5 K to 5.2 K (-19.74 %) |
Nov 04 2019 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Buy | M | 152.74 | 1,291 | 197,187 | 6,540 | 5.2 K to 6.5 K (+24.60 %) |